User profiles for R. A. Levy
Roger A LevyGSK Verified email at gsk.com Cited by 12720 |
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
…, RM Guzmán, AE Gallacher, S Hall, RA Levy… - The Lancet, 2011 - thelancet.com
Background Systemic lupus erythematosus is a heterogeneous autoimmune disease that is
associated with B-cell hyperactivity, autoantibodies, and increased concentrations of B-…
associated with B-cell hyperactivity, autoantibodies, and increased concentrations of B-…
Relative strength as a criterion for investment selection
RA Levy - The Journal of finance, 1967 - JSTOR
AN EXTENSIVE BODY of literature has recently emanated from scholarly sources stating
that successive stock market price changes are statistically independent (ie, that the study of …
that successive stock market price changes are statistically independent (ie, that the study of …
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …
specificity for use in observational studies and trials, jointly supported by the American …
Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients
…, A Burcoglu, K Lim, FJ Muñoz-Rodríguez, RA Levy… - Medicine, 1998 - journals.lww.com
The term “antiphospholipid syndrome”(APS) was introduced to describe patients presenting
with a combination of recurrent arterial and venous throm-bosis, recurrent fetal losses, often …
with a combination of recurrent arterial and venous throm-bosis, recurrent fetal losses, often …
[HTML][HTML] Anti-inflammatory and immunosuppressive drugs and reproduction
…, A Czeizel, JC Piette, R Cervera, RA Levy… - Arthritis research & …, 2006 - Springer
Rheumatic diseases in women of childbearing years may necessitate drug treatment during
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
RA Levy, VS Vilela, MJ Cataldo, RC Ramos… - Lupus, 2001 - journals.sagepub.com
We conducted a randomized, controlled study to assess the need for hydroxychloroquine (HCQ)
during lupus pregnancy and to assess safety. Twenty consecutive pregnant patients …
during lupus pregnancy and to assess safety. Twenty consecutive pregnant patients …
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study
G Singh, JG Fort, JL Goldstein, RA Levy… - The American journal of …, 2006 - Elsevier
… compared rofecoxib with naproxen in rheumatoid arthritis patients, and the Therapeutic …
in patients with osteoarthritis and rheumatoid arthritis, did not conclusively demonstrate a …
in patients with osteoarthritis and rheumatoid arthritis, did not conclusively demonstrate a …
On the short-term stationarity of beta coefficients
RA Levy - Financial Analysts Journal, 1971 - Taylor & Francis
THE measurement of risk is currently one of the more prominent topics in the investment
community. Perhaps the prominence is due to constant prodding from academic circles; …
community. Perhaps the prominence is due to constant prodding from academic circles; …
Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.
VJ Burroughs, RW Maxey, RA Levy - Journal of the National …, 2002 - ncbi.nlm.nih.gov
… The recent report of the Institute of Medicine (IOM), "Unequal Treatment: Confronting Racial
and Ethnic Disparities in Healthcare," illustrates in eloquent scientific detail that racial and …
and Ethnic Disparities in Healthcare," illustrates in eloquent scientific detail that racial and …
An image‐based approach for designing and manufacturing craniofacial scaffolds
SJ Hollister, RA Levy, TM Chu… - … Journal of Oral & …, 2000 - Wiley Online Library
Bone tissue engineering (BTE), which combines biomaterial scaffolds with biologically
active factors, holds tremendous promise for reconstructing craniofacial defects. A significant …
active factors, holds tremendous promise for reconstructing craniofacial defects. A significant …